Sublingual Immunotherapy in Allergic Rhinitis and Asthma

  • Paul Potter
Part of the Allergy Frontiers book series (ALLERGY, volume 5)

Since the recognition and approval of sublingual immunotherapy (SLIT) by the World Health Organization and the European Association of Allergy and Clinical Immunology in 1998 [1, 2], there was been a worldwide interest in the use of this treatment for allergic diseases.

Sublingual immunotherapy has been shown to be effective in rhinitis and asthma; it is extremely safe and unlike subcutaneous immunotherapy, represents a form of immunotherapy which can be used beyond the specialized allergy centers.


Allergic Rhinitis Allergy Clin Immunol Grass Pollen House Dust Mite Oral Tolerance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Malling HJ, Abreu-Noguera J, Alvaraz-Cresta E. Local immunotherapy. Allergy 1998; 53: 933–944CrossRefPubMedGoogle Scholar
  2. 2.
    Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases (A WHO position paper). Allergy 1998; 53 (Suppl 44): 1–42Google Scholar
  3. 3.
    Gozallo F, Martin S, Rico P, Alvarez E, Cortes C. Clinical efficacy and tolerance of 2 year Lolium Perenne sublingual immunotherapy. Allergol and Immunopathol 1997; 25(5): 219–227Google Scholar
  4. 4.
    Patriarca G, Nucera E, Pollestrini E, et al. Sublingual desensitization: a new approach to the latex allergy problem. Anesth Anal 2002; 95(4): 956–960CrossRefGoogle Scholar
  5. 5.
    Di Rienzo V, Marcucci F, Pucinilli P, et al. Long lasting effects of sublingual immunotherapy with asthma due to house dust mites: a 10 year prospective study. Clin Exp Allergy 2003; 33: 206–210CrossRefPubMedGoogle Scholar
  6. 6.
    Arikan C, Bahceciler N, Deniz G, Adkis M, Akkok T, Adkis C, Burlan I. Bacillus Calmette Guérin induced IL-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 2004; 3: 398–405CrossRefGoogle Scholar
  7. 7.
    Ippoliti F, De Santos W, Volterrani A, et al. Immunomodulation during sublingual immuno-therapy in allergic children. Paed Allergy Immunol 2003; 14(3): 216–221CrossRefGoogle Scholar
  8. 8.
    Marcucci F, Sensi L, Frati F, et al. Effects on inflammation parameters of a double blind, placebo controlled one-year course of SLIT in children monosensitised to mites. Allergy 2003; 58(7): 657–662CrossRefPubMedGoogle Scholar
  9. 9.
    Lima MT, Wilson D, Petkin L, et al. Grass pollen sublingual immunotherapy for seasonal conjunctivitis. Clin Exp Allergy 2002; 32: 507–514CrossRefPubMedGoogle Scholar
  10. 10.
    Silvestri M, Spaldarossa D, Buttistini E, et al. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity in asthmatic children sensitised to house dust mites following SLIT. J Invest Allergol Clin Immunol 2002; 12: 52–59Google Scholar
  11. 11.
    Passalacqua G, Albano M, Fregonese L, et al. Randomised clinical trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis. Lancet 1998; 351: 629–632CrossRefPubMedGoogle Scholar
  12. 12.
    Passalacqua G, Albano M, Riccio AM, et al. Clinical and immunological effects of a risk sublingual immunotherapy to Parietaria species: a double bind placebo controlled trial. J Allergy Clin Immunol 1999; 104: 964–968CrossRefPubMedGoogle Scholar
  13. 13.
    Silvestri M, Spallarossa D, Battistini E, et al. Changes in inflammatory and clinical parameters and in bronchial hyperactivity in asthmatic children sensitised to house dust mites following sublingual immunotherapy. J Investig Allergol Clin Immunol 2002; 12: 52–59PubMedGoogle Scholar
  14. 14.
    Wachholz P, Durham S. Mechanisms of immunotherapy IgG revisited. Curr Opin Allergy Immunol 2004; 4: 313–318CrossRefGoogle Scholar
  15. 15.
    Tari MG, Marciano M, Monti G, et al. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mites: a double blind study. Allergol Immunopath 1990; 18: 277–284Google Scholar
  16. 16.
    Adkis M, Schmidt-Weber C, Jutel M, Adkis L, Blaser K. Mechanisms of allergen immuno-therapy. Allergy Clin Immunol Int J World Allergy Org 2004; 16: 65–69CrossRefGoogle Scholar
  17. 17.
    Ben Mohamed L, Belkard Y, Loing E, Brahimi K, et al. Systemic immune responses induced by mucosal administration of lipo peptides without adjuvant. Eur J Immunol 2002; 32(8): 2274–2281CrossRefGoogle Scholar
  18. 18.
    Ciprandi G, Fenoglio D, Cirilli I, Vizzacaro A, Ferreira A, Tosca MA. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005; 95: 38–44PubMedGoogle Scholar
  19. 19.
    Bagnusco M, Manani G, Passalacqua G, Motta C, Falagiani P. Absorption and distributions kinetics of the major parietaria judaica allergen (Par j 1) administered by non-injectable routes in healthy human beings. J Allergy Clin Immunol 1997; 100: 122–129CrossRefGoogle Scholar
  20. 20.
    Jutel M, Adkis M, Blaser K, Adkis CA. Mechanisms of allergen specific immunotherapy: T cell tolerance and more. Allergy 2006; 61: 796–807CrossRefPubMedGoogle Scholar
  21. 21.
    Passalacqua G, Canonica G. Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol 2006; 6: 449–454CrossRefPubMedGoogle Scholar
  22. 22.
    Tonnel AB, Scherpereel A, Douay B, et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004; 59: 491–497CrossRefPubMedGoogle Scholar
  23. 23.
    Bufe A, Ziegler-Kirbach E, Stoeckmann E, et al. Efficacy of sublingual swallow immuno-therapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004; 59: 498–504CrossRefPubMedGoogle Scholar
  24. 24.
    Smith H, White P, Annita I, et al. Randomized controlled trial of high-dose sublingual immu-notherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004; 114: 831–837CrossRefPubMedGoogle Scholar
  25. 25.
    Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized double-blind, placebo-controlled multicentre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004; 59: 1285–1293CrossRefPubMedGoogle Scholar
  26. 26.
    Bowen T, Greenbaum J, Charbonneau Y, et al. Canadian trial of sublingual swallow immuno-therapy for ragweed rhinoconjunctivitis. Ann Allergy Asthma Immunol 2004; 93: 425–430PubMedGoogle Scholar
  27. 27.
    Dahl R, Stender H, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 2006; 61: 185–190CrossRefPubMedGoogle Scholar
  28. 28.
    Niu CK, Chen WY, Huang JL, et al. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multicentre, double-blind, randomized and placebo-controlled study in Taiwan. Respir Med 2006; 100: 1374–1383CrossRefPubMedGoogle Scholar
  29. 29.
    Passalacqua G, Pasquali M, Ariano R, et al. Randomized double blind controlled study with sublingual carbamylated allergoid in mild rhinitis due to mites. Allergy 2006; 61: 849–854CrossRefPubMedGoogle Scholar
  30. 30.
    Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass-allergen tablets: a randomised controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 802–809CrossRefPubMedGoogle Scholar
  31. 31.
    Wilson DR, Torres L, Durham SR. Sublingual immunotherapy for allergic rhinitis. Allergy 2005; 60: 3–8CrossRefGoogle Scholar
  32. 32.
    Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW. Meta analysis of sublingual immunotherapy in pediatric patients. Ann Allergy Asthma Immunol 2006; 97: 141–148PubMedCrossRefGoogle Scholar
  33. 33.
    Malling HR. Comparison of the clinical efficacy and safety of subcutaneous and sublingual immunotherapy: methodological approaches and experimental results. Current Opin Allergy Clin Immunol 2004; 4: 539–542CrossRefGoogle Scholar
  34. 34.
    Khinchi MS, Poulsen LK, Carat F, et al. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, doubleblind, double-dummy study. Allergy 2004; 59: 45–53CrossRefPubMedGoogle Scholar
  35. 35.
    Canonica W, Baena-Cagnani C, Bousquet J, Bousquet JP, Lockey RF, Malling HJ, Passalacqua G, Potter PC, Valovirta E. Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. Statement of a WAO — World Allergy Organization Task Force. Allergy 2007; 62: 316–324Google Scholar
  36. 36.
    Passalacqua G, Durham S. In corporation with the Global Allergy and Asthma and European Network (Ga2Len) (2007). Allergic Rhinitis and its impact on asthma. Update on allergen immunotherapy. J Allergy Clin Immunol 119: 881–891.CrossRefPubMedGoogle Scholar
  37. 37.
    Pajno GB, Passalacqua G, Vita D, Parmiani S, Barbeiro G. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with parietaria induced respiratory allergy: a randomized controlled trial. Allergy 2004; 59(8): 883–887CrossRefPubMedGoogle Scholar
  38. 38.
    Novembre E, Galli E, Landi F, Caffarelli C, Piffen M, De ME. Co-seasonal sublingual immu-notherapy reduces the development of asthma in children with allergic conjunctivitis. J Allergy Clin Immunol 2004; 114: 851–857CrossRefPubMedGoogle Scholar
  39. 39.
    Bufe A, Ziegler-Kirbach E, Stoeckman E, Heidermann P, Gehlhar K, Hollard Letz T. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen symptoms: a double blind placebo controlled study. Allergy 2004; 59: 498–504CrossRefPubMedGoogle Scholar
  40. 40.
    Marcucci F, Sensi L, Di GG, Salvatori S, Bernini M, Pecora S, et al. Three year follow up of clinical and inflammation parameters in children monosensitised to mites undergoing sublingual immunotherapy. Paediatr Allergy Immunol 2005; 16: 519–526CrossRefGoogle Scholar
  41. 41.
    Bordignon V, Burastero SE. Multiple daily administration of low dose sublingual immuno-therapy in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 2006; 97: 158–163PubMedCrossRefGoogle Scholar
  42. 42.
    Reider N. High dose sublingual immunotherapy: too much of the good! Ann Allergy 2006; 97: 125CrossRefGoogle Scholar
  43. 43.
    Berto P, Passalacqua G, Crimi N, Frati F, Ortolani M, Senna G, Canonica GW. Ann Allergy Asthma Immunol 2006; 97: 615–621Google Scholar
  44. 44.
    Passalacqua G, Guerra L, Pasquali M, Lombard C, Canonica GW. Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol 2004; 93: 3–12PubMedCrossRefGoogle Scholar
  45. 45.
    Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic patients. Allergy 2006; 61 (Suppl 81): 20–23CrossRefGoogle Scholar
  46. 46.
    Ippoliti F, De Santos W, Volteranni A, Caritario N, Frattolillo D, Lucarelli S, Frediani S, Frediani T. Psychological stress affects response to sublingual immunotherapy in asthmatic children allergic to house dust mite. Paediatr Allergy Immunol 2006; 17: 337–345CrossRefGoogle Scholar
  47. 47.
    Dunsky EH, Goldstein FM, Dvorin J, Bela-Canech G. Anaphylaxis to sublingual immuno-therapy. Allergy 2006; 61: 1235.CrossRefPubMedGoogle Scholar
  48. 48.
    Antico A, Pagan M, Crema A. Anaphylaxis by sublingual immunotherapy. Allergy 2006; 61: 1236.CrossRefPubMedGoogle Scholar
  49. 49.
    Potter PC, Thomas H, Terblanche L. Quality of life as a monitoring index and global score as an outcome index in sublingual immunotherapy for allergic rhinitis. Curr Allergy Clin Immunol 2006; 19(3): 161Google Scholar
  50. 50.
    Didier A, Melac M, Combebias A, Andre C. Efficacy and safety of sublingual immunotherapy tablets in grass pollen rhinoconjunctivitis. J Allergy Clin Immunol 2006; 117: 721 (abstract)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  1. 1.Allergy Diagnostic and Clinical Research UnitUniversity of Cape Town Lung InstituteMowbraySouth Africa

Personalised recommendations